ArticleHealthcare policy = Politiques de sante2022
University Technology Transfer Has Failed to Improve Access to Global Health Products during the COVID-19 Pandemic.
Article in Healthcare policy = Politiques de sante, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- Evolution of siRNA Therapeutics: From Mechanistic Foundations to Clinical Expansion.Pharmaceutics · 2026Review
- US public investment in development of mRNA covid-19 vaccines: retrospective cohort study.BMJ (Clinical research ed.) · 2023Article
- Article
- Implementation and impact of the global access principles at the University of British Columbia: current successes and future challenges.Frontiers in pharmacology · 2023Article
- Commentary: University Technology Transfer Has Made a Significant Contribution to Fighting COVID-19 while Ensuring Global Access.Healthcare policy = Politiques de sante · 2022Article
- Authors' Response - A Status Quo of Failure: Time to Fix University Technology Transfer to Address Global Health.Healthcare policy = Politiques de sante · 2022Article
- New Spending Programs and Old Frustrations: Where Is the Vision?Healthcare policy = Politiques de sante · 2022Article
- Commentary: Fulfilling the Promise of Global Access Licensing Principles to Enable Equitable Access.Healthcare policy = Politiques de sante · 2022Article
Corrections and comments
- Commented on by
- Commented on by
- Commented on by
Authors and funding
3 authors.
Funding
Abstract
Publicly funded research has contributed enormously to many products that were developed in the face of the COVID-19 pandemic. Yet universities' technology transfer practices have failed to ensure that these products are available in low- and middle-income settings. Drawing upon the example of the lipid nanoparticle delivery technology - which was developed in and around the University of British Columbia in Vancouver, BC, and incorporated into the Pfizer/BioNTech COVID-19 vaccine - we show the divide between the university's stated principles to serve global health and technology transfer in practice. We outline three policy actions to realign universities' technology transfer practices in the service of global health.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.